🇺🇸 Trivalent inactivated influenza vaccine in United States

20 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Coordination Abnormal — 2 reports (10%)
  2. Diabetic Neuropathy — 2 reports (10%)
  3. Drug Interaction — 2 reports (10%)
  4. Guillain-Barre Syndrome — 2 reports (10%)
  5. Infection — 2 reports (10%)
  6. Leukocytosis — 2 reports (10%)
  7. Mobility Decreased — 2 reports (10%)
  8. Pain — 2 reports (10%)
  9. Paraesthesia — 2 reports (10%)
  10. Paraplegia — 2 reports (10%)

Source database →

Trivalent inactivated influenza vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Trivalent inactivated influenza vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Trivalent inactivated influenza vaccine in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.